Denmark's stock market finished lower on Tuesday, with the OMX Copenhagen 20 slipping 1.10% at the close as sector-level declines in Oil & Gas, Healthcare and Financials outweighed gains elsewhere.
Market movers
Among the top performers on the OMX Copenhagen 20, FLSmidth & Co. (CSE:FLS) led advances, rising 4.54% - a gain of 22.60 points - to finish at 520.00. Logistics and freight group DSV Panalpina A/S (CSE:DSV) added 2.55% or 40.50 points to close at 1,629.00. NKT Holding (CSE:NKT) also closed higher, up 2.19% or 22.00 points to 1,028.00.
On the downside, Genmab (CSE:GMAB) registered the steepest drop, falling 5.77% or 94.50 points to end the session at 1,544.50. Zealand Pharma A/S (CSE:ZELA) declined 2.84% or 8.90 points to 304.70, while Novo Nordisk A/S Class B (CSE:NOVOb) retreated 2.54% or 7.30 points to 277.70.
Market breadth and context
On the Copenhagen Stock Exchange overall, declining issues outnumbered advancers by 68 to 54, and 14 stocks finished unchanged. The breadth figures reflect a session in which more names were under pressure than in gain territory.
Commodities and currencies
Energy and precious metals markets saw mixed movement. Crude oil for July delivery fell 0.34% or 0.31 to $91.85 a barrel, while Brent oil for August delivery eased 0.22% or 0.21 to $94.77 a barrel. In metals, the August Gold Futures contract rose 0.63% or 28.54 to trade at $4,534.84 a troy ounce.
In foreign exchange, USD/DKK was effectively unchanged, moving 0.03% to 6.42, and EUR/DKK was also little changed, moving 0.04% to 7.47. The US Dollar Index Futures was down 0.02% at 99.13.
What this means
The session saw selective strength in industrial and logistics names while heavyweight healthcare and financial stocks weighed on the index. Market breadth favored declines, signaling that the overall tone of trading was weak despite pockets of outperformance.
Investors monitoring Copenhagen equities will likely judge future sessions against whether today's sector-specific weakness broadens or if winners such as FLSmidth and DSV can sustain gains amid the softer market backdrop.